Foxc1 controls the growth of the murine frontal bone rudiment by direct regulation of a Bmp response threshold of Msx2

Development (Impact Factor: 6.46). 01/2013; 140(5). DOI: 10.1242/dev.085225
Source: PubMed


The mammalian skull vault consists of several intricately patterned bones that grow in close coordination. The growth of these bones depends on the precise regulation of the migration and differentiation of osteogenic cells from undifferentiated precursor cells located above the eye. Here, we demonstrate a role for Foxc1 in modulating the influence of Bmp signaling on the expression of Msx2 and the specification of these cells. Inactivation of Foxc1 results in a dramatic reduction in skull vault growth and causes an expansion of Msx2 expression and Bmp signaling into the area occupied by undifferentiated precursor cells. Foxc1 interacts directly with a Bmp responsive element in an enhancer upstream of Msx2, and acts to reduce the occupancy of P-Smad1/5/8. We propose that Foxc1 sets a threshold for the Bmp-dependent activation of Msx2, thus controlling the differentiation of osteogenic precursor cells and the rate and pattern of calvarial bone development.

  • Source
    • "Thus, FOXC1 also participated in the development of cancer by regulating the target genes. FOXC1 interacts with the Bmp-responsive enhancer to reduce Msx2 expression and contribute to skull vault growth in breast cancer[36]. MMP7 has a downstream effect on FOXC1-mediated invasiveness[37]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: MicroRNAs (miRNAs) are a class of noncoding RNAs and function as key regulators of gene expression at the post-transcriptional level. In this study, we found that miR-495 reduces cell growth, induces apoptosis and suppresses the migration of endometrial cancer by directly inhibiting FOXC1 expression. Further analysis revealed that FOXC1 promotes growth and migration and functions as an oncogene in vitro. FOXC1 overexpression reversed the cellular responses mediated by miR-495 in endometrial cancer cells. We also found that miR-495 suppresses the growth of endometrial cancer in vivo. Altogether, these results indicate that miR-495 acts as a tumour suppressor gene by targeting FOXC1 at the post-transcriptional level in endometrial cancer.
    Preview · Article · Jul 2015 · Tumor Biology
  • Source
    • "nents of BMP signaling pathway candidate genes for such human congenital disease . A recent study showed that deficiency of Foxc1 or Fgf8 also causes bony syng - nathia in mice ( Inman et al . , 2013 ) . Foxc1 acts to reduce the phosphorylation level of Smad1 / 5 / 8 , and repress BMP - dependent gene expression in the osteogenic precursor cells ( Sun et al . , 2013 ) . Specifically in the jaw , Foxc1 deficiency leads to decreased Fgf8 expression in the oral ectoderm of the first pharyngeal arch . Mice carrying compound mutations in both Foxc1 and Fgf8 , or in Fgf8 alone exhibit bony syngnathia phenotype , indicating a genetic interaction between these two genes in jaw development ."
    [Show abstract] [Hide abstract]
    ABSTRACT: Congenital bony syngnathia, a rare but severe human birth defect, is characterized by bony fusion of the mandible to the maxilla. However, the genetic mechanisms underlying this birth defect are poorly understood, largely due to limitation of available animal models. Here we present evidence that transgenic expression of Bmp4 in neural crest cells causes a series of craniofacial malformations in mice, including a bony fusion between the maxilla and hypoplastic mandible, resembling the bony syngnathia syndrome in humans. In addition, the anterior portion of the palatal shelves emerged from the mandibular arch instead of the maxilla in the mutants. Gene expression assays showed an altered expression of several facial patterning genes, including Hand2, Dlx2, Msx1, Barx1, Foxc2 and Fgf8, in the maxillary and mandibular processes of the mutants, indicating mis-patterned cranial neural crest (CNC) derived cells in the facial region. However, despite of formation of cleft palate and ectopic cartilage, forced expression of a constitutively active form of BMP receptor-Ia (caBmprIa) in CNC lineage did not produce the syngnathia phenotype, suggesting a non-cell autonomous effect of the augmented BMP4 signaling. Our studies demonstrate that aberrant BMP4-mediated signaling in CNC cells leads to mis-patterned facial skeleton and congenital bony syngnathia, and suggest an implication of mutations in BMP signaling pathway in human bony syngnathia.
    Full-text · Article · Apr 2014 · Developmental Biology
  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this study was to detect FOXC1 expression in gastric tissues and the clinical significance of FOXC1 in the development, progression and metastasis of GC patients. We screened the expression of FOXC1 in GC by Affymetrix U133 plus 2.0 Gene Chip Array and we found FOXC1 expression was significantly higher in GC tissues than in controls by microarray. Furthermore, we validated the expression levels of FOXC1 by real-time quantitative RT-PCR (qRT-PCR) and immunohistochemistry (IHC). Our study showed that the expression levels of FOXC1 mRNA and protein in GC tissues were significantly higher than those in corresponding non-tumor tissues. High expression of FOXC1 correlated with the degree of histological differentiation (P<0.01), TNM stage (P<0.001), invasive depth (P<0.05), lymph node metastasis (P<0.05) and distant metastasis (P<0.01). Survival analysis revealed that patients with high expression levels of FOXC1 showed lower overall survival rate than those with low expression levels (P<0.001). Multivariate analysis showed that high FOXC1 protein expression was an independent prognostic factor for GC patients (P<0.01). Up-expression of FOXC1 may play a key role in progression of GC, and FOXC1 expression may serve as a useful marker for predicting the outcome of patients with GC. This article is protected by copyright. All rights reserved.
    No preview · Article · Dec 2013 · Histopathology
Show more